Authors


Moon Jeong Lee, MD

Latest:

The impact of vision loss on aging: A glaucoma fellow’s perspective

Moon Jeong Lee, MD, shares how volunteering in geriatric care shaped her career path.


John C. Baldinger, MD

Latest:

Femtosecond laser-assisted cataract surgery: One physician’s story

Ophthalmologist outlines his journey with the procedure as a late adopter.


Elaine Ye Wang, MD

Latest:

BLOG: MicroPulse TLT for patients who struggle with drops

In cases where patients struggle with applying or tolerating eye drops, especially after previous selective laser trabeculoplasty (SLT) treatment, MicroPulse transscleral laser therapy (TLT) offers a practical solution.


Polat Goktas, PhD

Latest:

Ophthalmology balances the promises and challenges of AI

Sophisticated programs require an evolving mindset.


Jithin Yohannan, MD, MPH

Latest:

AGS 2025: Development and evaluation of an AI model to set target IOP with Jithin Yohannan, MD, MPH

An AI model for target IOP prediction performs as well as glaucoma specialists, offering a promising tool to enhance glaucoma management, especially for nonspecialists.


Peter Hnik, MD, MHSc

Latest:

Blog: Cannabinol, a rare cannabinoid, shows unique therapeutic potential in glaucoma

A recent study of cannabinol in in vitro and in vivo glaucoma models, demonstrated encouraging results that may address some of the previous challenges associated with cannabis use and may present a new potential therapeutic intervention in the treatment of glaucoma.


Akihiro Kakehashi, MD, PhD

Latest:

The truth about invisible posterior vitreous structures

The advanced swept-source OCT technology allows visualization of the variations in the normal changes and those associated with aging in the posterior vitreous.


Ashtyn Zapletal

Latest:

Pigskins and perception: How neuro-ophthalmology influences NFL referees

Every football fan knows the scrutiny that NFL game officials are put under every game day, and now a group of ophthalmologists is trying to ensure they can perform at their best each weekend.


Amanda Nanasy, OD

Latest:

Treating traumatic brain injury neuro-optometrically

Physicians note the impact of prism lenses can be life-changing for patients.


Allen C. Ho, MD, FACS, FASRS

Latest:

MCO-010 optogenetic gene therapy for severe vision loss in Stargardt disease

The treatment option can have a positive impact on quality of life for patients.


Brandon Kingrey, MD

Latest:

Innovation Series: Expanding access to eye care, advice for aspiring innovators from DMEI ophthalmology residents (part 3)

In this final episode, DMEI’s residents share their future plans for expanding the device capabilities and offer practical advice to other up-and-coming creators in eye care technology.


Jacob A. Rogers

Latest:

Study compares postoperative refractive accuracy of formula-modified keratometry values versus total keratometry values obtained by a swept-source OCT biometer with new-generation multivariable IOL calculation formulas

Older generation non-LVC formulas show marked improvement upon using TK values vs K, while multivariable non-LVC formulas did not consistently improve.


Xiaolin Wang, MS

Latest:

ARVO 2025: In vivo imaging of RPE metabolic function in AMD

At ARVO 2025, in Salt Lake City, Utah, Xiaolin Wang, MS, talked about her presentation on in vivo imaging of retinal pigment epithelium metabolic function in AMD.


Jella An, MD

Latest:

Netarsudil provides IOP lowering in goniotomy treated eyes

The unique MOA may deliver a synergistic effect when prescribed post-surgically.


Jeremiah Brown Jr, MD

Latest:

Shifting paradigm in GA management means focusing attention on imaging

Ophthalmologists can use OCT to find the early signs of disease


Andrew R. Harrison, MD

Latest:

Advancement in TED treatment is a bright spot

FDA approval of teprotumumab as therapeutic offers hope for patients.


Hsin-Yu Yang

Latest:

ARVO 2025: Efficacy of DIMS lenses in slowing myopic shifts among pre-myopic preschoolers

At ARVO 2025, in Salt Lake City, Utah, Hsin-Yu Yang talked about the 9-month results from her study on the effectiveness of DIMS spectral lenses in myopic retardation for the pre-myopic preschoolers in Taiwan.


Gerald J. Roper, MD

Latest:

Protecting cataract patients and their surgeons' practices

Maximizing refractive surgery is key to ensuring prosperous future


Steven A. Greenstein, MD

Latest:

IKA Keratoconus Symposium 2023: New data presented for epi-on cross-linking

John D. Gelles, OD, and Steven A. Greenstein, MD, share some insights into the new data on corneal cross-linking presented at IKA Keratoconus Symposium.


Colin R. Green, PhD, DSc

Latest:

Innovation Series: What a noninvasive eye drop approach may mean for the future of keratoconus

Ehsan Sadri, MD, FACS, of Visionary Eye Institute in Newport Beach, California, sat down with Professor Emeritus Colin R. Green, PhD, DSc, University of Auckland, in Auckland, New Zealand, to learn more about a novel therapy in development for the treatment of keratoconus and other corneal ectasias.


Bonnie An Henderson, MD

Latest:

ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery

AI’s use in diagnostic tools, surgical guidance, and its ethical considerations in ophthalmology are transforming the field


Christina Prescott, MD

Latest:

ARVO 2025: Stromal keratitis in the ZED study

Christina Prescott, MD, talks about the rate of recurrence of stromal keratitis in the Zoster Eye Disease Study, both in the placebo and in the treatment group.


Sunir Garg, MD

Latest:

Q&A: Sunir Garg, MD, shares insights on using chlorhexidine for anti-sepsis

Sunir Garg, MD, discusses a challenge in ophthalmological procedures: patient discomfort during intravitreal injections caused by povidone iodine.


Vicente Diaz, MD

Latest:

Tuning out anxiety: the role of music in cataract surgery

From easing fears to improving mood, a recent study explores how music transforms the surgical experience for both patients and health care teams.




Brittany Simmons, MD

Latest:

Envision Summit 2025: Advice on treating periorbital eye injuries

At the Envision Summit 2025 in San Juan, Puerto Rico, Brittany Simmons, MD, discussed periorbital injuries and how they can affect the soft tissue and bones around the eye and gives insight into how clinicians should best go about treating it.


Abby Markward, MBA

Latest:

Sneak preview: the ASCRS Foundation's blockbuster plans kick off in Los Angeles

Abby Markward, MBA, executive director of the ASCRS Foundation and ASOA, discusses the foundation's global initiatives and the ASCRS Party for a Purpose.


Majda Hadziahmetovic, MD

Latest:

Envision Summit 2025: Deep learning models of neovascular AMD

At the Envision Summit 2025 in San Juan, Puerto Rico, retina program chairs Geeta Lalwani, MD, and Majda Hadziahmetovic, MD, discussed Hadziahmetovic's presentation on deep learning models of neovascular AMD as well as their time at the conference.


S.K. Steven Houston III, MD, FASRS

Latest:

Welcome to the metaverse: Technology allows ophthalmologists to mingle with colleagues worldwide

Answers to common questions that can help kick-start the journey into the metaverse to learn from the many virtual educational meetings and conference opportunities while mingling with colleagues worldwide.

© 2025 MJH Life Sciences

All rights reserved.